Table 1 Demographic data of all participants in 2015.

From: Circulating Lipocalin-2 level is positively associated with cognitive impairment in patients with metabolic syndrome

Parameters

N = 191

Clinical parameters

Age (years)

64.53 ± 8.45

Female, n (%)

107 (56.02)

History of disease complications

 -Myocardial infarction

39 (20.42)

 -Stroke

5 (2.62)

Current smoker, n (%)

5 (2.62)

Current alcohol drinker, n (%)

33 (17.28)

BMI (kg/m2)

27.35 ± 5.36

WC (cm)

94.62 ± 12.93

Systolic BP (mmHg)

138.12 ± 17.86

Diastolic BP (mmHg)

74.38 ± 9.84

MoCA score

19.42 ± 4.72

Biological parameters

Hemoglobin (g/dL)

12.43 ± 1.72

WBC (cell/mm3)

7,939.61 ± 2,532.32

Triglycerides (mg/dL)

133.48 ± 69.23

LDL-C (mg/dL)

92.69 ± 35.44

HDL-C (mg/dL)

47.54 ± 14.64

FPG (mg/dL)

130.96 ± 54.31

HbA1C (%)

7.38 ± 1.70

HOMA index

2.77 ± 5.11

Creatinine (mg/dL)

1.34 ± 1.44

Serum LCN2 (ng/mL)

29.70 ± 16.75

  1. Data are presented as mean ± SD.
  2. BMI Body mass index, BP Blood pressure, FPG Fasting plasma glucose, HbA1c Glycated hemoglobin A1c, HDL-C High density lipoprotein cholesterol, HOMA index, Homeostasis Model Assessment index, LDL-C Low density lipoprotein cholesterol, LCN2 lipocalin-2, MoCA Montreal cognitive assessment, WBC White blood cell count, WC Waist circumference.
Back to article page